ATC code: G03AA11
As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.
The approved indication for norgestimate in combination with ethinylestradiol is contraception [1,2], and in some countries in hormone replacement therapy in combination with estradiol [2].
Updated: 2017-04-25
Date of litterature search: 2017-04-11
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson